DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4DR REDDYS
02 2ALKEM LABS LTD
03 2ANNORA PHARMA
04 1AUROBINDO PHARMA LTD
05 12BOEHRINGER INGELHEIM
06 1INVAGEN PHARMS
07 2KINAPSE LIMITED
08 4MSN
09 2MSN LABS PVT LTD
10 1MYLAN
11 3MYLAN PHARMS INC
12 3PRINSTON PHARMA INC
13 3SUN PHARM INDS LTD
14 4SUNSHINE
15 4ZYDUS PHARMS
01 6TABLET, EXTENDED RELEASE;ORAL
02 4TABLET; ORAL
03 38TABLET;ORAL
01 31RX
02 17Blank
01 3EMPAGLIFLOZIN AND LINAGLIPTIN
02 6EMPAGLIFLOZIN; LINAGLIPTIN
03 2GLYXAMBI
04 3JENTADUETO
05 2JENTADUETO XR
06 7LINAGLIPTIN
07 17LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
08 3LINAGLIPTIN; METFORMIN HYDROCHLORIDE
09 1TRADJENTA
10 4TRIJARDY XR
01 19No
02 12Yes
03 17Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Approval Date : 2025-11-03
Application Number : 208427
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Approval Date : 2025-11-03
Application Number : 208427
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Approval Date : 2025-11-03
Application Number : 208427
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 2025-11-03
Application Number : 208428
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : TRADJENTA
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 2011-05-02
Application Number : 201280
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Approval Date : 2012-01-30
Application Number : 201281
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Approval Date : 2012-01-30
Application Number : 201281
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Approval Date : 2012-01-30
Application Number : 201281
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;5MG
Approval Date : 2015-01-30
Application Number : 206073
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG;5MG
Approval Date : 2015-01-30
Application Number : 206073
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
